SUGAR LAND--July 9, 2008--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--An analysis of the top 10 North American Pharmaceutical & Biotech capital projects currently scheduled to begin construction in 2008 reveals a cumulative total investment value (TIV) of $2.9 billion. Although the figure is impressive, it is a 34% drop compared with the same analysis of last year's top 10 projects, which totaled $4.4 billion. Shire PLC's ( LSE:SHP ) (Chineham, England) Wayne, Pennsylvania, office remains at the top for 2008, followed by Massachusetts where Alexandria Real Estate Equities Incorporated ( NYSE:ARE ) (Pasadena, California) is in a joint venture to build a 250,000-square-foot facility.